EUVIMEDEUVIMED entdecken
Leitlinie

3832 Reducing the use of lorazepam and increasing adherence to the delirium guideline using Epic® digital search functions

3832 Reduzierung des Einsatzes von Lorazepam und Verbesserung der Leitlinienadhärenz bei Delir mithilfe digitaler Epic®-Suchfunktionen

J Yates, L Stones, N Tollemache, S Mather

Age and Ageing · 05.02.2026 · 55 (Supplement_1)

DOI: 10.1093/ageing/afaf368.036 ↗

Auf einen Blick

In einer Qualitätsverbesserungsmaßnahme sank die Lorazepam-Verordnung bei Delir um 70 %. Gleichzeitig nahm der Einsatz nichtpharmakologischer Maßnahmen zu.

Fragestellung

Soll die Adhärenz zur Delir-Leitlinie verbessert werden, indem Lorazepam reduziert und nichtpharmakologische Maßnahmen stärker genutzt werden?

Methode

Qualitätsverbesserungsprojekt im Manchester Royal Infirmary; Fallidentifikation über Epic®-EPR; 4 Wochen Basisdaten, danach Poster und erneute Datenerhebung.

Ergebnisse

Baseline erhielten im Mittel 8,75 Patient:innen pro Woche eine pharmakologische Delirbehandlung, danach 2,6 pro Woche. Lorazepam-Verordnungen sanken um 70 %; kein Anstieg von Haloperidol.

Schlussfolgerung der Autor:innen

Die Autor:innen berichten, dass als nächste Schritte ein spezielles Verordnungsschema für Delir eingeführt werden soll, mit ähnlichen Informationen wie auf den Postern und Verknüpfung zur Leitlinie.

Kernaussagen

  • Lorazepam-Verordnungen sanken um 70 %
  • Pharmakologische Delirbehandlung: 8,75 vs. 2,6 Patient:innen/Woche
  • Nichtpharmakologische Maßnahmen, inkl. Verhaltenstabellen, nahmen zu

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Leitlinie in der Zeitschrift Age and Ageing, online erschienen am 05.02.2026. Verfasst von J Yates und 3 weiteren Autor:innen.

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Despite it’s known deliriogenic properties, and contrary to trust guidelines, lorazepam is often used first line in the management of delirium at Manchester Royal Infirmary without a documented rationale. This project aims to improve adherence to trust delirium guidance—reducing the use of lorazepam in the pharmacological management of delirium and improving compliance with non-pharmacological elements.

Methods

Case identification was carried out using the hospital’s Electronic Patient Record (EPR) system, Epic®. A report was created to display patients with a coded diagnosis of ‘Delirium,’ however, following assessment of the data quality it became clear that this report was failing to capture the expected patient population. A further report was created which displayed patients who had been prescribed medications used in delirium (Lorazepam, Haloperidol, Quetiapine, Olanzapine); data was collected over a 4-week period and patients who had been prescribed one of these medications for an alternative indication were excluded. Once baseline data had been collected, a programme of education took place. This involved the distribution of posters which outlined key nursing steps, summarised the non-pharmacological and pharmacological management of delirium—highlighting haloperidol as first line and signposting to the full guideline. Data was then recollected using the same dashboard.

Results

There was a significant drop in the prescription of lorazepam by 70%. An average of 8.75 patients received pharmacological management for their delirium per week at baseline. This reduced to 2.6 patients per week following poster distribution. There was no corresponding increase in the use of haloperidol, with lorazepam remaining the first choice for the small number receiving pharmacological management. There was a significant increase in the use of non-pharmacological tools including behaviour charts.

Conclusion

Next steps include implementing a bespoke order set for prescribing in delirium with similar information to the distributed posters and linked to the delirium guidance.

Zitieren

APA

Yates, J., Stones, L., Tollemache, N., & Mather, S. (2026). 3832 Reducing the use of lorazepam and increasing adherence to the delirium guideline using Epic® digital search functions. Age and Ageing, 55(Supplement_1). https://doi.org/10.1093/ageing/afaf368.036

Vancouver

Yates J, Stones L, Tollemache N, Mather S. 3832 Reducing the use of lorazepam and increasing adherence to the delirium guideline using Epic® digital search functions. Age and Ageing. 2026;55(Supplement_1). doi:10.1093/ageing/afaf368.036

BibTeX
@article{Yates2026,
  author = {Yates, J and Stones, L and Tollemache, N and Mather, S},
  title = {3832 Reducing the use of lorazepam and increasing adherence to the delirium guideline using Epic® digital search functions},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {Supplement_1},
  doi = {10.1093/ageing/afaf368.036}
}
Kostenlos starten →